Where are the phase IIb results for Bimatoprost?

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • allTheGoodNamesAreTaken
    replied
    Quel ****ing surprise.

    Leave a comment:


  • barfacan
    replied
    It's over fellas, close this thread. BIM is a BUST

    Leave a comment:


  • JayM
    replied
    Well the guy asked if they were kidding... so I thought it was best to mention that it being used for glaucoma hasn't come out the blue. So it certainly has value to the guy I wrote it to pal.

    Leave a comment:


  • maver1ck
    replied
    Originally posted by JayM
    Well it is used for treating glaucoma...
    Does that have any value to us?

    Leave a comment:


  • JayM
    replied
    Well it is used for treating glaucoma...

    Leave a comment:


  • Pelopeleon
    replied
    Originally posted by maver1ck
    Allergan released their q2 report and there is only 1 mention of BIM and its that its starting phase 3 as a treatment for glaucoma
    As a treatment for glaucoma? Are you f**** kidding me?

    Well, I was waiting for some good news...

    Leave a comment:


  • JayM
    replied
    Joke

    Leave a comment:


  • maver1ck
    replied
    Allergan released their q2 report and there is only 1 mention of BIM and its that its starting phase 3 as a treatment for glaucoma

    Leave a comment:


  • BiqqieSmalls
    replied
    Originally posted by It's2014ComeOnAlready
    They'll most likely talk about the Kythera acquisition, the selling of its generics, and hopefully something about bimatoprost.

    Poster "Biqqiesmalls" is a shareholder, and he spoke with investor relations back in May. They refused to tell him anything initially, but was promised that they'd look into it for him. He got a call 2 days later, and was told that results were not released yet, even to shareholders, the reason they haven't released results yet was because of the "complexity of bimatoprost," and that they'd release results "in a few months."

    I trust the word of that representative because she looked into it for him, and called him back. So, I doubt she would lie.

    I thought the selling of all its generics, including finasteride, was interesting because of their interest in commercializing set and bim. Probably of no consequence, but whatever.
    I had to call them back; the woman's explanation was ambiguous. Can't wait to check the report when I head into work

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Originally posted by JayM
    I hope they do mention it but I wouldn't be surprised if the recent purchase of their generics drugs department takes up most of it. I mean it was a massive deal!
    They'll most likely talk about the Kythera acquisition, the selling of its generics, and hopefully something about bimatoprost.

    Poster "Biqqiesmalls" is a shareholder, and he spoke with investor relations back in May. They refused to tell him anything initially, but was promised that they'd look into it for him. He got a call 2 days later, and was told that results were not released yet, even to shareholders, the reason they haven't released results yet was because of the "complexity of bimatoprost," and that they'd release results "in a few months."

    I trust the word of that representative because she looked into it for him, and called him back. So, I doubt she would lie.

    I thought the selling of all its generics, including finasteride, was interesting because of their interest in commercializing set and bim. Probably of no consequence, but whatever.

    Leave a comment:


  • JayM
    replied
    I hope they do mention it but I wouldn't be surprised if the recent purchase of their generics drugs department takes up most of it. I mean it was a massive deal!

    Leave a comment:


  • maver1ck
    replied
    Originally posted by Pelopeleon
    Tomorrow is realeased some info about bimatoprost, right?
    Yes. Something like 8:45 AM they release q2 report. But one member on this thread remarked that they might not release any information, and will instead wait until january when they have to divulge by law. If they dont release any information, then Im not to sure how confident I am about BIM. However, people have heard good things and maybe they are actually going to release something.

    Leave a comment:


  • Pelopeleon
    replied
    Tomorrow is realeased some info about bimatoprost, right?

    Leave a comment:


  • maver1ck
    replied
    Originally posted by It's2014ComeOnAlready
    Interesting thought - don't know if it means anything, but since Allergan sold all of its generics business to Teva, that includes generic finasteride.
    Can you fill me in as to why that would mean something? Honest question

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Interesting thought - don't know if it means anything, but since Allergan sold all of its generics business to Teva, that includes generic finasteride.

    Leave a comment:

Working...